April 27, 2026 April 27, 2026Categories Announcements News StoriesThe April 2026 News from ECOG-ACRIN blog is now available
April 8, 2026 April 8, 2026Categories News StoriesECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials
April 8, 2026 April 8, 2026Categories News StoriesGroup co-chair Dr. Mitchell Schnall named a health system chief digital officer to know in 2026
March 30, 2026 March 30, 2026Categories Announcements News StoriesThe March 2026 News from ECOG-ACRIN blog is now available
March 24, 2026 March 24, 2026Categories News StoriesECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk
February 27, 2026 February 27, 2026Categories Announcements News StoriesThe February 2026 News from ECOG-ACRIN blog is now available
February 13, 2026 February 13, 2026Categories Announcements News StoriesThe Winter 2026 advocacy blog Considering Clinical Trials is now available
February 9, 2026 February 9, 2026Categories News StoriesNatasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials
February 3, 2026 February 3, 2026Categories News StoriesECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations
